NCT02718846View on ClinicalTrials.gov

Isobide Solution and Meniace Tablets Compared to Monotherapy With Meniace Tablets

PHASE4CompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Meniere's Disease
Interventions
DRUG

Meniace

6 mg of Meniace tablets were administered 3 times per day after meals

DRUG

Isobide

an initial dosage of 90 mL of Isobide solution was administered orally 3 times a day after meals

Sponsors

Lead Sponsor

Alvogen Korea
All Listed Sponsors
lead

Alvogen Korea

INDUSTRY